| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |